nounIntermediate
Definition
Selective growth hormone secretagogue pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH₂) that stimulates GH release from the pituitary without significantly affecting cortisol, prolactin, or ACTH levels — making it one of the most selective GHRP compounds.
Detailed Explanation
Selective growth hormone secretagogue pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH₂) that stimulates GH release from the pituitary without significantly affecting cortisol, prolactin, or ACTH levels — making it one of the most selective GHRP compounds. Ipamorelin binds the ghrelin receptor (GHS-R1a) and synergizes with GHRH analogs like CJC-1295. It is not FDA-approved and is used primarily in research and off-label peptide therapy protocols.
Key Facts
- Selective growth hormone secretagogue pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH₂) that stimulates GH release from the pituitary without significantly affecting cortisol, prolactin, or ACTH levels — making it one of the most selective GHRP compounds.
- Ipamorelin binds the ghrelin receptor (GHS-R1a) and synergizes with GHRH analogs like CJC-1295.
- It is not FDA-approved and is used primarily in research and off-label peptide therapy protocols.
Part of the PeptideBond.com education network